Genomic organization and partial duplication of the human α7 neuronal nicotinic acetylcholine receptor gene (CHRNA7)

Genomics

Volumn 52, Issue 2, 1998, Pages 173-185

  Gault, Judith ^a   Robinson, Misi ^a   Berger, Ralph ^a   Drebing, Carla ^a   Logel, Judith ^a   Hopkins, Jan ^a   Moore, Ted ^a   Jacobs, Suzette ^a   Meriwether, Jennifer ^a   Choi, Mun Jun ^a   Kim, Eun Jung ^a   Walton, Katy ^a   Buiting, Karin ^b   Davis, Ashley ^a   Breese, Charles ^a   Freedman, Robert ^a   Leonard, Sherry ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINIC RECEPTOR; RECEPTOR SUBUNIT;

ALTERNATIVE RNA SPLICING; ARTICLE; BINDING SITE; BRAIN; CHROMOSOME 15; CLINICAL ARTICLE; EXON; FEMALE; GENE DUPLICATION; GENE EXPRESSION; GENE STRUCTURE; GENETIC VARIABILITY; HUMAN; INTRON; MALE; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; RECEPTOR GENE; SEQUENCE HOMOLOGY; TATA BOX;

BOVINAE;

EID: 0032168029     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1006/geno.1998.5363     Document Type: Article

References (75)

1. Adcock I. M., Barnes P. J. Ligand-induced differentiation of glucocorticoid receptor (GR) transrepression and transactivation. Biochem. Soc. Trans. 24:1996.
2. Adler G. K., Smas C. M., Fiandaca M., Frim D. M., Majzoub J. A. Regulated expression of the human corticotropin releasing hormone gene by cyclic AMP. Mol. Cell. Endocrinol. 70:1990;165-174.
3. Adler L. E., Hoffer L. D., Wiser A., Freedman R. Normalization of auditory physiology by cigarette smoking in schizophrenic patients. Am. J. Psych. 150:1993;1856-1861.
4. Adler L. E., Hoffer L. J., Griffith J., Waldo M. C., Freedman R. Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics. Biol. Psych. 32:1992;607-616.
5. Albertsen H. M., Abderrahim H., Cann H. M., Dausset J., Le Paslier D., Cohen D. Proc. Natl. Acad. Sci. USA. 87:1990;4256-4260.
6. Alkondon M., Albuquerque E. X. Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. I. Pharmacological and functional evidence for distinct structural subtypes. J. Pharmacol. Exp. Ther. 265:1993;1455-1473.
7. Amar M., Thomas P., Johnson C., Lunt G. G., Wonnacott S. Agonist pharmacology of the neuronal α7 nicotinic receptor expressed inXenopus. FEBS. 327:1993;284-288.
8. Barnes W. M. PCR amplification of up to 35 kb DNA with high fidelity and high yields from lambda templates. Proc. Natl. Acad. Sci. USA. 91:1994;2216-2220.
9. Beeson D., Morris A., Vincent A., Newsom-Davis J. The human muscle nicotinic acetylcholine receptor α-subunit exists as two isoforms: A novel exon. EMBO J. 9:1990;2101-2106.
10. Bessis A., Savatier N., Devillers-Thiery A., Bejanin S., Changeux J. P. Negative regulatory elements upstream of a novel exon of the neuronal nicotinic acetylcholine receptor alpha 2 subunit gene. Nucleic Acids Res. 21:1993;2185-2192.
11. Bickford P. C., Wear K. D. Restoration of sensory gating of auditory evoked response by nicotine in fimbria-fornix lesioned rats. Brain Res. 705:1995;235-240.
12. Blount P., Merlie J. P. Mutational analysis of muscle nicotinic acetylcholine receptor subunit assembly. J. Cell Biol. 111:1990;2613-2622.
13. Boel E., Vuust J., Norris F., Norris K., Wind A., Rehfeld J. E., Marcker K. A. Molecular cloning of human gastric cDNA: Evidence for evolution of gastrin by gene duplication. Proc. Natl. Acad. Sci. USA. 80:1983;2866-2869.
14. 125. J. Comp. Neurol. 387:1997;385-398.
15. Brownstein B. H., Silverman G. A., Little R. D., Burke D. T., Korsmeyer S. J., Schlessinger D., Olson M. V. Isolation of single-copy human genes from a library of yeast artificial chromosome clones. Science. 244:1989;1348-1351.
16. Buiting K., Dittrich B., Endele S., Horsthemke B. Identification of novel exons 3′ to the humanSNRPN. Genomics. 40:1997;132-137.
17. Burke D. T., Carle G. F., Olson M. V. Cloning of large segments of exogenous DNA into yeast by means of artificial chromosome vectors. Science. 236:1987;806-812.
18. Campbell L., Potter A., Ignatius J., Dubowitz D., Davies K. Genomic variation and gene conversion in spinal muscular atrophy: Implications for disease process and clinical phenotype. Am. J. Hum. Genet. 61:1997;40-50.
19. Cao X. M., Koski R. A., Gashler A., McKiernan M., Morris C. F., Gaffney R., Hay R. V., Sukhatme V. P. Identification and characterization of the Egr-1 gene product, a DNA-binding zinc finger protein induced by differentiation and growth signals. Mol. Cell. Biol. 10:1990;1931-1939.
20. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocynanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
21. Christian S., Bhatt N. K., Martin S. A., Sutcliffe J. S., Kubota T., Huang B., Mutirangura A., Chinault A. C., Beaudet A. L., Ledbetter D. H. Integrated YAC contig map of the Prader-Willi/Angelman region on chromosome 15q11-q13 with average STS spacing of 35 kb. Genome Res. 8:1998;146-157.
22. Chumakov I., Rigault P., Guillou S., Ougen P., Billaut A., Guasconi G., Gervy P., LeGall I., Soularue P., Grinas L. Continuum of overlapping clones spanning the entire human chromosome 21q. Nature. 359:1992;380-387.
23. Collins A. C., Bhat R. V., Pauly J. R., Marks M. J. Modulation of nicotine receptors by chronic exposure to nicotinic agonists and antagonists. Ciba Found. Symp. 152:1990;68-82.
24. Conti-Tronconi B. M., Dunn S. M. J., Barnard E. A., Dolly J. O., Lai F. A., Ray N., Raftery M. A. Brain and muscle nicotinic acetylcholine receptors are different but homologous proteins. Proc. Natl. Acad. Sci. USA. 82:1985;5208-5212.
25. Cooper E., Couturier S., Ballivet M. Pentameric structure and subunit stoichiometry of a neuronal nicotinic acetylcholine receptor. Nature. 350:1991;235-238.
26. Couturier S., Bertrand D., Matter J.-M., Hernandez M.-C., Bertrand S., Millar N., Valera S., Barkas T., Ballivet M. A neuronal nicotinic acetylcholine receptor subunit α7 is developmentally regulated and forms a homo-oligomeric channel blocked by α-BTX. Neuron. 5:1990;847-856.
27. Criado M., Dominguez d. T., Carrasco-Serrano C., Smillie F. I., Juiz J. M., Viniegra S., Ballesta J. J. Differential expression of alpha-bungarotoxin-sensitive neuronal nicotinic receptors in adrenergic chromaffin cells: A role for transcription factor Egr-1. J. Neurosci. 17:1997;6554-6564.
28. Den-Dunnen J. T., Grootscholten P. M., Bakker E., Blonden L. A., Ginjaar H. B., Wapenaar M. C., van P. H., van-Broeckhoven C., Pearson P. L., van-Ommen G. J. Topography of the Duchenne muscular dystrophy (DMD) gene: FIGE and cDNA analysis of 194 cases reveals 115 deletions and 13 duplications. Am. J. Hum. Genet. 45:1989;835-847.
29. Deneris E. S., Boulter J., Connolly J., Wada E., Wada K., Goldman D., Swanson L. W., Patrick J., Heinemann S. Genes encoding neuronal nicotinic acetylcholine receptors. Clin. Chem. 35:1989;731-737.
30. Dittrich B., Buiting K., Korn B., Rickard S., Buxton J., Saitoh S., Nicholls R. D., Poustka A., Winterpacht A., Zabel B., Horsthemke B. Imprint switching on human chromosome 15 may involve alternative transcripts of the SNRPN gene. Nature. 14:1996;163-170.
31. Dracopoli N. C., Haines J. L., Korf B. R., Moir D. T., Morton C. C., Seidman C. E., Seidman J. G., Smith D. R. Current Protocols in Human Genetics. 1994;Wiley, New York.
32. Drouin J., Charron J., Gagner J. P., Jeannotte L., Nemer M., Plante R. K., Wrange O. Pro-opiomelanocortin gene: A model for negative regulation of transcription by glucocorticoids. J. Cell. Biochem. 35:1987;293-304.
33. Elgoyhen A. B., Johnson D. S., Boulter J., Vetter D. E., Heinemann S. Alpha 9: An acetylcholine receptor with novel pharmacological properties expressed in rat cochlear hair cells. Cell. 79:1994;705-715.
34. Fornasari D., Bataglioli E., Flora A., Terzano S., Clementi F. Structural and functional characterization of the human alpha-3 nicotinic subunit gene promoter. Mol. Pharmacol. 51:1997;250-261.
35. Freedman R., Adler L. E., Bickford P., Byerley W., Coon H., Cullum C. M., Griffith J. M., Harris J. G., Leonard S., Miller C., Myles-Worsley M., Nagamoto H. T., Rose G., Waldo M. C. Schizophrenia and nicotinic receptors. Harvard Rev. Psych. 2:1994;179-192.
36. Freedman R., Coon H., Myles-Worsley M., Orr-Urtreger A., Olincy A., Davis A., Polymeropoulos M., Holik J., Hopkins J., Hoff M., Rosenthal J., Waldo M. C., Reimherr R., Wender P., Yaw J., Young D. A., Breese C. R., Adams C., Patterson D., Adler L. E., Kruglyak L., Leonard S., Byerley W. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc. Natl. Acad. Sci. USA. 94:1996;587-592.
37. Freedman R., Hall M., Adler L. E., Leonard S. Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia. Biol. Psych. 38:1995;22-33.
38. Freedman R., Waldo M., Bickford-Wimer P., Nagamoto H. Elementary neuronal dysfunctions in schizophrenia. Schiz. Res. 4:1991;233-243.
39. Frohman M. A. Rapid amplification of cDNA ends (RACE): User-friendly cDNA cloning. Amplifications. 5:1990;11-15.
40. Galzi J.-L., Revah F., Bessis A., Changeux J.-P. Functional architecture of the nicotinic acetylcholine receptor: From electric organ to brain. Annu. Rev. Pharmacol. 31:1991;37-72.
41. Garcia-Guzman M., Sala F., Sala S., Campos-Caro A., Stuhmer W., Gutierrez L. M., Criado M. Alpha-Bungarotoxin-sensitive nicotinic receptors on bovine chromaffin cells: Molecular cloning, functional expression and alternative splicing of the alpha 7 subunit. Eur. J. Neurosci. 7:1995;647-655.
42. Gashler A., Sukhatme V. P. Early growth response protein 1 (Egr-1): Prototype of a zinc-finger family of transcription factors. Prog. Nucleic Acid Res. Mol. Biol. 50:1995;191-224.
43. Goldman D., Deneris E., Luyten W., Kochhar A., Patrick J., Heinemann S. Members of a nicotinic acetylcholine receptor gene family are expressed in different regions of the mammalian central nervous system. Cell. 48:1987;965-973.
44. Gonzalez G. A., Montminy M. R. Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell. 59:1989;675-680.
45. Green M. R. Biochemical mechanisms of constitutive and regulated pre-mRNA splicing. Annu. Rev. Cell Biol. 7:1991;559-599.
46. Hu X., Worton R. G. Partial gene duplication as a cause of human disease. Hum. Mutat. 1:1992;3-12.
47. Lamond A. I. The spliceosome. BioEssays. 15:1993;595-603.
48. Legradi G., Holzer D., Kapcala L. P., Lechan R. M. Glucocorticoids inhibit stress-induced phosphorylation of CREB in corticotropin-releasing hormone neurons of the hypothalamic paraventricular nucleus. Neuroendocrinology. 66:1997;86-97.
49. Lehrman M. A., Goldstein J. L., Russell D. W., Brown M. S. Duplication of seven exons in the LDL receptor gene caused by Alu-Alu recombination in a subject with familial hypercholesterolemia. Cell. 48:1987;827-835.
50. Leonard S., Adams C., Breese C. R., Adler L. E., Bickford P., Byerley W., Coon H., Griffith J. M., Miller C., Myles-Worsley M., Nagamoto H. T., Rollins Y., Stevens K. E., Waldo M., Freedman R. Nicotinic receptor function in schizophrenia. Schiz. Bull. 22:1996;431-445.
51. Lindstrom J., Anand R., Peng X., Gerzanich V., Wang F., Li Y. Neuronal nicotinic receptor subtypes. Ann. N. Y. Acad. Sci. 757:1996;100-116.
52. Lukas R. J., Bencherif M. Heterogeneity and regulation of nicotinic acetylcholine receptors. Int. Rev. Neurobiol. 34:1992;25-130.
53. Luntz-Leybman V., Bickford P. C., Freedman R. Cholinergic gating of response to auditory stimuli in rat hippocampus. Brain Res. 587:1992;130-136.
54. Marks M. J., Collins A. C. Characterization of nicotine binding in mouse brain and comparison with the binding of α-bungarotoxin and quinuclidinyl benzilate. Mol. Pharmacol. 22:1982;554-564.
55. Marks M. J., Stitzel J. A., Romm E., Wehner J. M., Collins A. C. Nicotinic binding sites in rat and mouse brain: Comparison of acetylcholine, nicotine and α-bungarotoxin binding. Mol. Pharmacol. 30:1986;427-436.
56. Matter-Sadzinski L., Hernandex M-C., Roztocil R., Ballivet M., Matter J-M. Neuronal specificity of the α7 nicotinic acetylcholine receptor promoter develops during morphogenesis of the central nervous system. EMBO J. 11:1992;4529-4538.
57. McGehee D. S., Role L. W. Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annu. Rev. Phys. 57:1995;521-546.
58. Miller S. A., Dykes D. D., Polesky H. F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16:1988.
59. Montminy M. R., Bilezikjian L. M. Binding of a nuclear protein to the cyclic-AMP response element of the somatostatin gene. Nature. 328:1987;175-178.
60. Newland C. F., Beeson D., Vincent A., Newsom-Davis J. Functional and non-functional isoforms of the human muscle acetylcholine receptor. J. Phys. 489:1995;767-778.
61. Park I., Schaeffer E., Sidoli A., Baralle F. E., Cohen G. N., Zakin M. M. Organization of the human transferrin gene: Direct evidence that it originated by gene duplication. Proc. Natl. Acad. Sci. USA. 82:1985;3149-3153.
62. Patrick J., Boulter J., Goldman D., Gardner P., Heinemann S. Molecular biology of nicotinic acetylcholine receptors. Ann. N. Y. Acad. Sci. 505:1987;194-207.
63. Pauly J. R., Grun E. U., Collins A. C. Glucocorticoid regulation of sensitivity to nicotine. The Biology of Nicotine: Current Research Issues. 1992;Raven Press, New York. p. 121-139.
64. Sambrook J., Fritsch E. F., Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
65. Sargent P. B. The diversity of neuronal nicotinic acetylcholine receptors. Annu. Rev. Neurosci. 16:1993;403-443.
66. Schoepfer R., Conroy W. G., Whiting P., Gore M., Lindstrom J. Brain α-bungarotoxin binding protein cDNAs and MAbs reveal subtypes of this branch of the ligand-gated ion channel gene superfamily. Neuron. 5:1990;35-48.
67. Seasholtz A. F., Thompson R. C., Douglass J. O. Identification of a cyclic adenosine monophosphate-responsive element in the rat corticotropin-releasing hormone gene. Mol. Endocrinol. 2:1988;1311-1319.
68. Séguéla P., Wadiche J., Dineley-Miller K., Dani J. A., Patrick J. W. Molecular cloning, functional properties, and distribution of rat brain α7: A nicotinic cation channel highly permeable to calcium. J. Neurosci. 13:1993;596-604.
69. Stevens K. E., Freedman R., Collins A. C., Hall M., Leonard S., Marks M. J., Rose G. M. Genetic correlation of inhibitory gating of hippocampal auditory evoked response and α-bungarotoxin-binding nicotinic cholinergic receptors in inbred mouse strains. Brain Res. 15:1996;152-162.
70. Stevens K. E., Meltzer J., Rose G. M. Nicotinic cholinergic normalization of amphetamine-induced loss of auditory gating in freely moving rats. Psychopharmacology. 119:1995;163-170.
71. 2+. Neuron. 8:1992;353-362.
72. von Heijne G. A new method for predicting signal sequence cleavage sites. Nucleic Acids Res. 14:1986;4683-4690.
73. Wada E., Wada K., Boulter J., Deneris E., Heinemann S., Patrick J., Swanson L. W. Distribution of alpha 2, alpha 3, alpha 4, and beta 2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: A hybridization histochemical study in the rat. J. Comp. Neurol. 284:1989;314-335.
74. Wonnacott S. α-Bungarotoxin binds to low-affinity nicotine binding sites in rat brain. J. Neurochem. 47:1986;1706-1712.
75. Zhang Z-W., Vijayaraghavan S., Berg D. K. Neuronal acetylcholine receptors that bind α-bungarotoxin with high affinity function as ligand-gated ion channels. Neuron. 12:1994;167-177.